
    
      Participants will be scheduled for study sessions on 2 consecutive days to include consent,
      baseline audiometric evaluation, intra-tympanic contrast administration, serial MR imaging,
      and follow-up audiometry evaluation in the injected ear.

      Participants over 59 years old or who have medical conditions will have a blood test to check
      kidney function to ensure they can safely receive the contrast.
    
  